J&J Ketamine Nasal Spray Approved for Depression
President and CEO of Cardiol Therapeutics Inc. David Elsley discusses the rise in heart failure deaths among young adults on ‘Making Money’. Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-based nasal spray to help millions of American patients…